Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

4

About Amarpreet Sawhney

Dr. Sawhney is currently the President and CEO of Confluent Surgical and Managing Directors in Incept LLC. His inventions have formed the basis for the founding of several medical device and biotechnology companies and their products.

Headquarters Location

Bedford, Massachusetts,

United States

Want to inform investors similar to Amarpreet Sawhney about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Amarpreet Sawhney Investments

4 Investments

Amarpreet Sawhney has made 4 investments. Their latest investment was in Axtria as part of their Series C - II on May 5, 2015.

CBI Logo

Amarpreet Sawhney Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/13/2015

Series C - II

Axtria

$24.4M

No

2

1/6/2015

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/9/2014

Series B

Subscribe to see more

$99M

Subscribe to see more

10

5/13/2010

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/13/2015

1/6/2015

1/9/2014

5/13/2010

Round

Series C - II

Series C

Series B

Series A

Company

Axtria

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$24.4M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.